Antibodies against four major EBV antigens (viral capsid antigen (anti-VCA) IgA, IgM and IgG, early antigen (anti-EA) IgG, EBV nuclear antigen (EBNA), and ZEBRA IgM) have been studied in association with the risk of various cancers. This evidence concerns the gene CD40LG and cancer.